Viridian Therapeutics, Inc. · NASDAQ:VRDN
The Vanguard Group's stake in Viridian Therapeutics, Inc. fell below 5% (Schedule 13G/A)
Event Mar 13, 2026 · Filed Mar 27, 2026
The Vanguard Group's stake in Viridian Therapeutics, Inc. fell below 5%, 0 shares, as a passive investor on Mar 13, 2026. Filed Mar 27, 2026 (Schedule 13G/A).
- Stake
- 0%
- Shares
- 0
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 0% | 0 |
Source
Related
- Viridian Therapeutics, Inc.
- The Vanguard Group
- Viridian Therapeutics, Inc. shareholders
- Form 4 · Tousignant Jennifer · Aug 20, 2026
- Schedule 13G · Point72 Asset Management, L.P. · Aug 20, 2026
- Form 4 · Tripuraneni Radhika · Aug 18, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Aug 14, 2026
- Schedule 13G/A · Paradigm Biocapital Advisors LP · Aug 14, 2026